Gastroenterology: Study on the prevalence of functional bowel disease that meets Rome IV standards

Recently, researchers conducted a cross-country study to examine the prevalence, distribution and effects of patients with functional bowel disease (FBD) that met the Rome IV standardresearchers analyzed data from participants in the United States, Canada and the United Kingdom, with a total of 5,931 valid respondents, 49.2% of women, with an average age of 47.4 yearsThe survey included the Rome-IV Diagnostic Questionnaire, Rome-III Irritable Bowel Syndrome (IBS), Constipation, and the SF-8 Quality of Life Questionnairecensus-adjusted incidence of Rome IV FBD is similar in the three countries, ranging from 4.4%-4.8% to IBS, 7.9%-8.6% functional constipation, 3.6%-5.3% functional diarrhea, and functional swelling or bloating It is 2.0%-3.9%, opioid-induced constipation is 1.1%-1.9%, other FBDs are 7.5%-10.0%, and the overall incidence of Rome IV FBD is 28.6%-31.7%In addition to functional diarrhea, FBDs are less common in older patients, but are more common in womenAccording to the Rome IV standard, IBS is only half the incidence of Rome III (4.6% vs 9.0%), but there is an increase in functional diarrhea and functional constipation patientsCompared with other subjects, the quality of life of subjects with FBD decreased significantly and the number of gastrointestinal visits increasedstudy found that about 25 percent of adults in the general population met the standards for Rome IV functional bowel disease, and the prevalence of irritable bowel syndrome was reduced by half under the Rome IV criteria, but the prevalence of functional constipation and functional diarrhea increased significantly